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Background: The opioid epidemic is complex and concerning, but of particular 
concern is insufficient addiction therapy and mortality from opioid-related overdose. 
Lack of addiction management increases the likelihood of an individual presenting to the 
Emergency Department (ED) for an opioid-related overdose. Medication Assisted 
Therapy (MAT) has been shown to reduce opioid use, reduce opioid related mortality, 
and can be initiated in the ED. Objective: We sought to identify local factors that could 
affect MAT uptake and better understand the feasibility of employing a MAT program 
through our local community hospital’s  ED. Methods: We employed a single center, 
retrospective cohort study in patients who presented to our Hospital’s ED with an opioid-
related emergency between January 1, 2018 to August 31, 2019. Results: A total of 
1,440 patients presented with an opioid-related emergency over 17 months. There were 
1,974 visits with opioid-related ICD10 codes, and 305 patients accounted for 41% of all 
opioid-related ED visits. Only 15% of patients were discharged to other facilities for 
potential substance use disorder treatment. Rate of mortality was 6 /1,000 opioid related 
ED patient visits. Conclusion: White males in their 20’s through 30’s appear to have the 
highest risk for an opioid-related ED visit. It was common for patients to present multiple 
times with another opioid incident, but most likely survive the emergency and be 
discharged home.  





 The opioid epidemic is a multifaceted and complex problem, but of particular 
concern are over-prescription of opioids, increased addiction, insufficient addiction 
therapy, and increased mortality from opioid-related overdose (1-3). On-going addiction 
to opioids and lack of addiction management increases the likelihood of an individual 
presenting to Emergency Departments (ED) once or repeatedly for an opioid-related 
overdose (3). This behavior puts a financial burden on the healthcare system and 
increases the chance the patient dies due to the overdose (2). Nationally in 2018, 
opiates were involved in almost 47,000 deaths (4). In 2018 1,718 NC residents died 
from an unintentional opioid-related overdose (5). Buncombe County, located in 
Western North Carolina, had 71 opioid-related deaths in 2018 (5). 
Multiple acts of legislation, both in North Carolina and nationally, were 
passed to address factors that contribute to the opioid epidemic. Examples of 
statutes include The Drug Addiction Treatment Act (DATA) of 2000 and the North 
Carolina STOP Act of 2017 (6,7). While some aspects of the opioid epidemic 
have begun to be addressed by governing bodies and healthcare professionals, 
addiction and sufficient treatment of addiction are lagging behind (2,3). According 
to the 2015 American Society of Addiction Medicine (ASAM) Guidelines, 
counseling and psychological therapy, in conjunction with pharmacologic therapy 
or medication assisted therapy (MAT) are the recommended means for 
addressing opioid use disorder (OUD) (8). MAT entails using buprenorphine with 
or without naloxone, or methadone to reduce the use of illicit substances in an 
opioid-dependent individual. MAT has been shown to reduce opioid use, prevent 
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transmission of infectious diseases such as HIV and Hepatitis C, and reduce 
opioid related mortality (7).  
In order to expand patient access to MAT, hospitals, and specifically EDs, 
have begun to implement MAT programs. The EDs at Yale New Haven Hospital 
in New Haven, CT, Massachusetts General Hospital in Boston, MA, and Sacred 
Heart Medical Center in Spokane, WA are three locations in which MAT in the 
ED setting have been successfully implemented. At Yale, evidence has shown 
that utilizing the ED to initiate MAT increases engagement of addiction therapy 
compared to referral to outpatient MAT alone, decreases self-reported illicit 
opioid use, and decreases use of inpatient addiction services (9). Further, 
evidence has shown that initiating MAT in the ED is more cost-effective than 
referral when considering healthcare system-associated costs (10). EDs with 
established MAT programs have identified key factors related to the successful 
adoption and implementation of MAT programs, including how to increase 
provider buy-in for implementation. For example, at Sacred Heart, educating 
providers about the cost-effectiveness of MAT and the degree of the opioid 
problem, have both contributed to physician buy-in to MAT (11).  
MAT has been shown to reduce opioid use, prevent transmission of 
infectious diseases such as HIV, and reduce opioid related mortality (7). While 
ED implemented MAT programs have begun to emerge nationwide, to our 
knowledge, the ED-implemented MAT program at Mission Hospital is the first in 
Asheville and the state of North Carolina. There are unique contextual issues in 
Buncombe County, including availability of outpatient MAT services, and number 
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of DATA 2000-waivered providers, which may affect the uptake and 
implementation of the program. Thus, we sought to identify local problems within 
Asheville and Buncombe County that could affect uptake. Finally, we hoped to 
translate the success of other hospitals and understand the feasibility of 
employing a MAT program through our Hospital’s ED. To do this we 
retrospectively reviewed out patient population for opioid related ED visits and 
subsequent discharge dispositions.  
 
Methods 
Study Design and Population 
This single center, retrospective cohort study included patients ≥ 18 years of age 
who were treated in our Hospital’s ED between January 1, 2018 to August 31, 2019. 
Our ED is a level 2 trauma center and serves a referral center for 17 counties. In 
addition to ≥ 18 years of age, patients also needed to have an opioid-related emergency 
which was defined by any opioid-related ICD10 code assigned to a patient as their chief 
complaint upon ED presentation. Patients who were admitted to the hospital were 
excluded. This study was approved by our Hospital’s and HCA Healthcare Institutional 
Review Board. Due to the retrospective nature of the study, informed consent was not 
required.  
Data Abstraction and Study Endpoints 
Clinical, and demographic data were electronically abstracted from Cerner, 
Mission’s electronic health record system. Patients were only included if they were ≥ 18 
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years of age, and also had any opioid-related ICD10 code assigned as their chief 
complaint upon ED presentation. A list of opioid-related ICD10 codes are provided in 
Supplemental Figure A. The primary endpoint was to determine the amount of opiate-
related ED visits to Mission Hospital. Secondary endpoints included patient 
demographics, discharge dispositions, and identification of patients with multiple opioid-
related ED visits.  
Statistical Analysis 
 Descriptive statistics were used to asses total visits, demographics, and 
discharge dispositions. Data are reported as counts (% of total population) and mean ± 
standard deviation. Male and female sex were compared using Pearson’s chi-square. 
Analyses were performed using SAS v9.4 (Cary, NC). P-values <0.05 were considered 




A summary of study workflow can be found in Figure 1. The mean age was 
33±14 years, 35% were in their twenties, 30% in their thirties, 18% in their forties, 9% in 
their fifties, 9% in their sixties or greater (Table 1). Males presented 1.5 times for 
frequently than females (P <.001). Whites made up the largest proportion of patients, 
followed by blacks, patients who refused to disclose their race, and other (Table 1). 
Patients presented from a wide array of communities, however 70% of all patients were 
Buncombe County residents, and 45% of all patients were Asheville residents. 
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Patient Visits and Discharge Dispositions  
A total of 1,440 patients led to a sum of 1,974 opioid-related ED visits from 
January 1, 2018 – August 31, 2019. Most patients did not report back to the ED with 
another opioid-related emergency. However, 305 patients had more than one opioid-
related ED visit, leading to 818 (41%) of the total 1,974 visits. A breakdown of patients 
who presented with more than one opioid-related ED visit can be seen in Figure 2. At 
the time of data completion, there was a total of 1,963 discharge dispositions with the 
majority being home, psychiatric facility, against medical advice, and rehabilitation 
(Table 2). Of the total discharge dispositions, only 15% of patients were discharge to an 
















Opioid-related ICD10 codes were identified 
and ran through Mission’s internal 
electronic health information database from 
January 1, 2018 – August 31, 2019
Excluded: Patients < 18 
years old, non-opioid-
related ICD10 visit, 
hospital admission





Patient Characteristic (N=1,440) n (%) 
Male Sex 873 (60.63) P< 0.001 
Female Sex 574 (39.86) 
Age Group 
 
20 – 29 502 (34.86) 
30 – 39 435 (30.21) 
40 – 49 254 (17.64) 
50 – 59 126 (8.75) 
≥ 60 123 (8.54) 
Race 
 
Black or African American 98 (6.81) 
White 1304 (90.56) 
Patient refuses or does not know 17 (1.18) 
Other 21 (1.46) 














































Patient's with > 1 opioid-related ED Visit
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Discharge Disposition (N=1,966)of n (%)visitID 
Routine/Home 1487 (75.64) 
Disch/Trans to Psychiatric Facility 210 (10.68) 
Discharge to Rehab 78 (3.97) 
Discharge to Law Enforcement (Jail) 43 (2.19) 
Discharge to Skilled Nursing Facility 7 (0.36) 
Discharge to Assisted Living 3 (0.15) 
Disch/Trans to Critical Access Hospital 2 (0.1) 
Discharge to Intermediate Care Facility 1 (0.05) 
Disch/Trans to Acute Care Hospital 1 (0.05) 
Disch/Trans Federal Health Care Facility 1 (0.05) 
Hospice - Medical Facility 1 (0.05) 
Discharged Other Healthcare Institution 1 (0.05) 
AMA (Left Against Medical Advice) 81 (4.12) 
LBTC (Left Before Treatment Complete) 36 (1.83) 
LWBS (Left Without Being Seen) 3 (0.15) 
LTC Facility 1 (0.05) 
Expired 12 (0.61) 
Table 2. Breakdown of discharge dispositions of opioid-related ED visits from January 1, 





 We sought to better identify opioid-related ED visits presenting to our community 
Hospital. Specifically, we sought to understand the local patient population by using 
demographic data of patients who were only treated in the ED and were not admitted. 
Additionally, we used discharge dispositions to understand if patients were going to 
other locations to potentially receive additional treatment. Our results suggest that 
opioid-related emergencies are common at our Hospital. The population who most 
commonly present with an opioid-related emergency is a white male in his twenties or 
thirties and a resident in the county where we are located. It was also common for 
patients to present multiple times with another opioid incident. While an overwhelming 
majority of patients managed in the ED were discharged routinely home and mortality 
was low. 
 Interestingly, opioid-related emergencies that ended in mortality only occurred at 
a rate of 6 per 1,000 patients. This suggests that the majority of patients who present to 
Mission with an opioid-related emergency survive. Nationally in 2018, opiates were 
involved in almost 47,000 deaths (4). In North Carolina, North Carolina Department of 
Health and Human Services reported that 1,718 residents have died from an 
unintentional opioid-related overdose in 2018 (5). Opiate mortality both nationally and 
within North Carolina, are trending down however. This downward trend needs further 
exploration in order to be fully explained. However, some factors that could be 
contributing include controlled substance prescription laws such as the North Carolina 
STOP Act, and increased awareness and/or access to MAT.  
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 Our study also investigated where patients were going after discharge. We found 
that 76% of all patients were discharged home, and only 15% of patients were 
discharged to an additional facility including another hospital, long-term care facility, or 
psychiatric facility. We also found that 305 patients came back to Mission with another 
opioid-related emergency and accounted for 41% of all opioid-related ED visits. Risk 
factors for overdose death include psychological etiologies and history of substance 
abuse (12).  These data indicate that a subset of the population could have a 
psychiatric, opiate or other substance use disorder, among other risk factors that 
increase the likelihood of an opioid mortality. Additionally, only 15% of total patients 
were discharged to other facilities including psychiatric facilities. This indicates that the 
majority of patients are not getting additional treatment for potential psychiatric 
disorders, including OUD. Both counseling and psychological therapy, in conjunction 
with MAT are the recommended means for addressing OUD in the ASAM Guidelines 
(8). Because the majority of patients who presented to the ED with an opioid-related 
emergency were local county residents, there is greater likelihood of follow-up with MAT 
treatment in these patients should it be initiated in our ED. Our results show that there is 
room for improvement in order to ensure that patients who present with an opioid-
related emergency, get the necessary treatment or referral in order to minimize risk of 
re-presentation.  
 This study does have limitations however and could impact the interpretation of 
the data. The choice of doing a single-center does create selection bias and does limit 
extrapolation of the opioid epidemic in areas outside of region. Patients that present 
with opioid-emergencies, regardless of hospital location, present similarly however. Our 
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data analysis was also conducted in a narrow window of time. This does not give us 
information regarding long-term following of these patients, and only represents a 
handful of visits. Misclassification bias is also a concern based on validity of the EHR. 
However, broad use of opiate-related ICD10’s allowed for capturing a larger patient 
population.  
Our data does not capture patients that refused emergency transport, patients 
who died from opioid-related overdose outside of the ED, or patients who were admitted 
to the hospital from the ED. This most likely implies that our results are lower than that 
representative of the entire region. To get a better understanding of the volume of 
mortality associated with the opioid epidemic in local Health and Human Services data 
can be analyzed. Local EMS data could be of benefit in order to gain further insight into 
understanding how many overdose responses don’t receive medical transport.  
The results from this study allow us to better understand the volume of patients 
presenting to our ED with an opioid-associated emergency. The knowledge we learned 
from this study indicates that MAT could provide benefit at our hospital’s ED. 
Additionally, this data will allow us to conduct future aims. We plan to use this data to 
educate emergency providers on hospital-specific numbers of opioid-emergencies, in 
hopes that they become DATA 2000-waivered to increase MAT availability to patients 
with OUD. Immediately prior and following the education session, a survey should be 
conducted to assess provider likelihood to become DATA-2000 waivered and prescribe 
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 Lack of addiction management increases the likelihood of an individual 
presenting to the Emergency Department (ED) for an opioid-related overdose. 
Medication Assisted Therapy (MAT) has been shown to reduce opioid use, reduce 
opioid related mortality, and can be initiated in the ED. What does this study attempt to 
show? We sought to identify local factors that could affect MAT uptake and better 
understand the feasibility of employing a MAT program through Mission Hospital’s ED. 
What are the key findings? A total of 1,440 patients presented with an opioid-related 
emergency over 17 months. A total of 305 patients accounted for 41% of all opioid-
related ED visits, with only 15% of all patients being discharged to seek additional 
substance abuse treatment. How is patient care impacted? There is room for 
improvement with MAT access. Increased access can potentially prevent patients from 
re-presenting to the ED with another opioid-related emergency and decrease risk for 
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willingness to prescribe MAT. These aims were originally projected to be completed on 
the same day. For Aims 3 and 4 the specific plan was to develop two MAT surveys and 
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to conduct an education session via PowerPoint to emergency providers. Two surveys 
were to be printed, and the initial pre-education session survey handed out prior to the 
start of the session. After the collection of all initial surveys, the education session was 
to be conducted. Finally, the post-education survey would then be given out. The only 
difference between the two surveys was to be the addition of one question related to 
post-session likelihood to become waivered to prescribe MAT. Results from both 
surveys were then going to be analyzed to determine the likelihood of emergency 







Diagnosis Description FINs 
F11.10 Opioid abuse, uncomplicated 525 
F11.11 Opioid abuse, in remission 14 
F11.120 Opioid abuse with intoxication, uncomplicated 6 
F11.121 Opioid abuse with intoxication delirium 1 
F11.129 Opioid abuse with intoxication, unspecified 5 
F11.14 Opioid abuse with opioid-induced mood disorder 2 
F11.150 Opioid abuse with opioid-induced psychotic disorder with 
delusions 
1 
F11.20 Opioid dependence, uncomplicated 1220 
F11.21 Opioid dependence, in remission 40 
F11.220 Opioid dependence with intoxication, uncomplicated 1 
F11.229 Opioid dependence with intoxication, unspecified 1 
F11.23 Opioid dependence with withdrawal 265 
F11.24 Opioid dependence with opioid-induced mood disorder 7 
F11.259 Opioid dependence with opioid-induced psychotic disorder, 
unspecified 
2 
F11.288 Opioid dependence with other opioid-induced disorder 4 
F11.29 Opioid dependence with unspecified opioid-induced disorder 187 
F11.90 Opioid use, unspecified, uncomplicated 208 
F11.920 Opioid use, unspecified with intoxication, uncomplicated 1 
F11.921 Opioid use, unspecified with intoxication delirium 5 
F11.929 Opioid use, unspecified with intoxication, unspecified 1 
F11.93 Opioid use, unspecified with withdrawal 3 
F11.94 Opioid use, unspecified with opioid-induced mood disorder 1 
F11.951 Opioid use, unspecified with opioid-induced psychotic disorder 
with hallucinations 
1 
F11.988 Opioid use, unspecified with other opioid-induced disorder 3 
F11.99 Opioid use, unspecified with unspecified opioid-induced 
disorder 
47 
R06.03 Acute respiratory distress 294 
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T40.1X1A Poisoning by heroin, accidental (unintentional), initial 
encounter 
178 
T40.1X2A Poisoning by heroin, intentional self-harm, initial encounter 6 
T40.1X4A Poisoning by heroin, undetermined, initial encounter 29 
T40.2X1A Poisoning by other opioids, accidental (unintentional), initial 
encounter 
74 
T40.2X2A Poisoning by other opioids, intentional self-harm, initial 
encounter 
13 
T40.2X4A Poisoning by other opioids, undetermined, initial encounter 38 
T40.2X5A Adverse effect of other opioids, initial encounter 188 
T40.3X1A Poisoning by methadone, accidental (unintentional), initial 
encounter 
14 
T40.3X5A Adverse effect of methadone, initial encounter 7 
T40.4X1A Poisoning by other synthetic narcotics, accidental 
(unintentional), initial encounter 
46 
T40.4X2A Poisoning by other synthetic narcotics, intentional self-harm, 
initial encounter 
10 
T40.4X4A Poisoning by other synthetic narcotics, undetermined, initial 
encounter 
7 
T40.4X5A Adverse effect of other synthetic narcotics, initial encounter 27 
T40.5X1A Poisoning by cocaine, accidental (unintentional), initial 
encounter 
20 
T40.5X2A Poisoning by cocaine, intentional self-harm, initial encounter 2 
T40.5X4A Poisoning by cocaine, undetermined, initial encounter 6 
T40.5X5A Adverse effect of cocaine, initial encounter 5 
T40.601A Poisoning by unspecified narcotics, accidental (unintentional), 
initial encounter 
141 
T40.602A Poisoning by unspecified narcotics, intentional self-harm, initial 
encounter 
7 
T40.604A Poisoning by unspecified narcotics, undetermined, initial 
encounter 
3 
T40.605A Adverse effect of unspecified narcotics, initial encounter 124 
T40.691A Poisoning by other narcotics, accidental (unintentional), initial 
encounter 
1 
T40.692A Poisoning by other narcotics, intentional self-harm, initial 
encounter 
1 
T40.695A Adverse effect of other narcotics, initial encounter 3 
T40.7X1A Poisoning by cannabis (derivatives), accidental (unintentional), 
initial encounter 
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T40.7X4A Poisoning by cannabis (derivatives), undetermined, initial 
encounter 
1 
T40.7X5A Adverse effect of cannabis (derivatives), initial encounter 4 
T40.8X1A Poisoning by lysergide [LSD], accidental (unintentional), initial 
encounter 
1 
T40.8X4A Poisoning by lysergide [LSD], undetermined, initial encounter 3 
T40.901A Poisoning by unspecified psychodysleptics [hallucinogens], 
accidental (unintentional), initial encounter 
1 
T40.905A Adverse effect of unspecified psychodysleptics 
[hallucinogens], initial encounter 
1 
T40.991A Poisoning by other psychodysleptics [hallucinogens], 
accidental (unintentional), initial encounter 
1 
Supplemental Table 1. Opioid-related emergency defined by Diagnosis Code (ICD10 




There was a recent study by D’Onofrio and colleagues (JAMA, 2015) that showed that ED-
initiated buprenorphine improved rates of engagement in addiction treatment when compared 
with referral to outpatient care.   
Open-Ended Questions  
What do you believe are the advantages of starting buprenorphine for patients with opioid use 
disorder in the ER? 
What do you believe are the disadvantages of starting buprenorphine to patients with opioid 
use disorder in the ER? 
Is there anything else you associate with or would like to share about your own views about 
prescribing buprenorphine to patients with opioid use disorder during an ER visit? 
Are there any individual or groups who would approve of your prescribing buprenorphine to 
patients with opioid use disorder during an ER visit? 
Are there any individual or groups who would disapprove of your prescribing buprenorphine to 
patients with opioid use disorder during an ER visit? 
Is there anything else you associate with other people’s views about prescribing buprenorphine 
to patients with OUD during an ER visit? 
What factors or circumstances would ENABLE you to prescribe buprenorphine to patients with 
opioid use disorder during an ER visit? 
What factors or circumstances would make it DIFFICULT or IMPOSSIBLE for you to prescribe 
Buprenorphine to patients with opioid use disorder during an ER visit? 
Are there any other issues that come to mind when you think about prescribing buprenorphine 





Prescribing buprenorphine to patients with opioid use disorders is 
                harmful 1  2  3  4  5  6  7  beneficial 
             good 1  2  3  4  5  6  7  bad 
      pleasant (for me) 1  2  3  4  5  6  7  unpleasant (for me) 
              worthless 1  2  3  4  5  6  7  useful 
1.  Most people who are important to me think that 
 
    I should 1   2   3   4   5   6   7   I should not 
 
  prescribe buprenorphine to patients with opioid use disorder. 
 
2. It is expected of me that I prescribe buprenorphine to patients with opioid use disorder. 
    
  Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
3. I feel under social pressure to prescribe buprenorphine to patients with opioid use disorder. 
 




4. People who are important to me want me to prescribe buprenorphine to patients with opioid 
use disorder. 
 
   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
Self-efficacy 
1. I am confident that I could prescribe buprenorphine to patients with opioid use disorder if 
I wanted to 
 
   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
 
2. For me to prescribe buprenorphine to patients with opioid use disorder is 
 




3. The decision to prescribe buprenorphine to patients with opioid use disorder is beyond 
my control. 
 
   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 





   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
Intention (8 hour waiver course) 
 
1. I expect to get waivered to prescribe buprenorphine for patients with opioid use disorders 
  
   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
2. I want to get waivered to prescribe Buprenorphine to patients with opioid use disorders 
 
   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
3. I intend to get waivered to prescribe buprenorphine to patients with opioid use disorders 
 
   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
4.  I would be more likely to take the 8-hour required course to prescribe buprenorphine if 
provided with: 
 




Monetary compensation Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
Paid Time Off   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
 
5.  I would be more likely to prescribe buprenorphine in the ED setting: 
 
With on-call specialist consultation:     Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
With outpatient follow-up availability:   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
If my colleagues were also doing it:   Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
 
If it did not require an 8-hr training:    Strongly disagree   1   2   3   4   5   6   7   Strongly agree 
Intention Simulation 
The first patient is a 29-year-old female, who comes into the emergency room late at night 
complaining of feeling nauseous, vomiting, anxious, and sweating. She states that she is 
suffering from withdrawals after using heroin in the morning. She indicates that she began using 
heroin 8 months ago and that her usage of the drug has gradually increased over time. She is 
very concerned about his drug use and wants to stop using the drug. She has no other ongoing 
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medication conditions. She also states that this is his first time visiting the emergency room for 
help with her drug use. 
Your decision: Prescribe Buprenorphine?     YES      NO 
On the scale 1 to 7, how difficult was it for you to make a decision for this scenario? 
 
  Not at all Difficult   1   2   3   4   5   6   7   Extremely Difficult 
 
 
The second patient is a 49-year-old male, who comes into the emergency room complaining of 
constipation and trouble breathing. You asked the patient if he used any drugs recreationally 
and he denied any drug use. Upon physical examination, you noticed that the patient’s pupil’s 
are constricted and that the pupil is intermittently nodding off. Based on his symptoms and exam 
findings, you decided to perform a drug panel on the patient. The drug panel returned positive 
for opiate use. You confront the patient with the test results and the patient finally admits to 
abusing fentanyl after being put on the medication for his chronic back pain several years ago. 
Your decision: Prescribe Buprenorphine?  YES      NO 
On the scale 1 to 7, how difficult was it for you to make a decision for this scenario? 
 





The third patient is a 16-year-old male, who comes into the emergency room with his mother 
who states that she concerned about her son’s drug use. You asked the patient if he used any 
drugs recreationally and he states that he uses oxycodone with his friends. He also indicates 
that he began using the drug with a group of friends about 3 months ago and does not see a 
problem with his drug use if he is enjoying himself. The patient’s mother is very concerned for 
her son’s health and wants to know if anything could be done to curtail or help treat his drug 
use. 
Your decision: Prescribe Buprenorphine?  YES      NO 
On the scale 1 to 7, how difficult was it for you to make a decision for this scenario? 
 
  Not at all Difficult   1   2   3   4   5   6   7   Extremely Difficult 
 
The fourth patient is a 35-year-old female, who comes into the emergency room late at night 
complaining of headaches, fatigue, and inability to sleep for the past several days. She states 
that she has been using morphine recreationally for 1 year in order to cope with the multiple 
stresses in her life after being promoted at her job. She wants to stop using the drug but is 
unsure of how to seek help. She indicates that she has been seen several times in the 
emergency room for similar problems. 
Your decision: Prescribe Buprenorphine?   YES     NO 
On the scale 1 to 7, how difficult was it for you to make a decision for this scenario? 
 




The fifth patient is a 25-year-old male, who comes into the emergency room late via the 
ambulance after overdosing on heroin. You and the nursing staff were able to stabilize the 
patient before the patient was hospitalized for further monitoring and care. A couple of weeks 
later, the same person visits the emergency room during your evening shift and is suffering from 
symptoms of withdrawals after using heroin the previous night. He states that he has been using 
heroin ever since his high school graduation party. He indicates that he open to stopping his 
heroin use due to the impact the drug has had on his life. 
Your decision: Prescribe Buprenorphine?  YES      NO 
On the scale 1 to 7, how difficult was it for you to make a decision for this scenario? 
 
  Not at all Difficult   1   2   3   4   5   6   7   Extremely Difficult 
 
Supplemental Methods 1. MAT survey created by Dr. Lindsey Jennings and her 
colleagues at Medical University of South Carolina which will be modified for Aims 3 and 
4. 
 
 
 
 
 
 
 
